<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26</volume><submitter>Sato A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Hereditary breast and ovarian cancer (HBOC) is a major type of hereditary cancer. Establishing effective screening to identify high-risk individuals for HBOC remains a challenge. We developed a prototype of a chatbot system that uses artificial intelligence (AI) for preliminary HBOC screening to determine whether individuals meet the National Comprehensive Cancer Network BRCA1/2 testing criteria.&lt;h4>Objective&lt;/h4>This study's objective was to validate the feasibility of this chatbot in a clinical setting by using it on a patient population that visited a hospital.&lt;h4>Methods&lt;/h4>We validated the medical accuracy of the chatbot system by performing a test on patients who consecutively visited the Kanagawa Cancer Center. The participants completed a preoperation questionna</pubmed_abstract><journal>Journal of medical Internet research</journal><pagination>e48914</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11635313</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study.</pubmed_title><pmcid>PMC11635313</pmcid><pubmed_authors>Sato A</pubmed_authors><pubmed_authors>Haneda E</pubmed_authors><pubmed_authors>Narimatsu H</pubmed_authors><pubmed_authors>Hiroshima Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study.</name><description>&lt;h4>Background&lt;/h4>Hereditary breast and ovarian cancer (HBOC) is a major type of hereditary cancer. Establishing effective screening to identify high-risk individuals for HBOC remains a challenge. We developed a prototype of a chatbot system that uses artificial intelligence (AI) for preliminary HBOC screening to determine whether individuals meet the National Comprehensive Cancer Network BRCA1/2 testing criteria.&lt;h4>Objective&lt;/h4>This study's objective was to validate the feasibility of this chatbot in a clinical setting by using it on a patient population that visited a hospital.&lt;h4>Methods&lt;/h4>We validated the medical accuracy of the chatbot system by performing a test on patients who consecutively visited the Kanagawa Cancer Center. The participants completed a preoperation questionna</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-03T23:26:10.957Z</modification><creation>2025-04-03T23:26:10.957Z</creation></dates><accession>S-EPMC11635313</accession><cross_references><pubmed>39602801</pubmed><doi>10.2196/48914</doi></cross_references></HashMap>